CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Jan 27, 2026, 12:28 PM EST
CNBX Pharmaceuticals Market Cap
CNBX Pharmaceuticals has a market cap or net worth of $130.62 thousand as of January 27, 2026. Its market cap has decreased by -65.01% in one year.
Market Cap
130.62K
Enterprise Value
1.37M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 20, 2011, CNBX Pharmaceuticals's market cap has decreased from 238.06K to 130.62K, a decrease of -45.13%. That is a compound annual growth rate of -4.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 26, 2026 | 174.15K | -42.20% |
| Dec 31, 2025 | 301.28K | 30.86% |
| Dec 31, 2024 | 230.22K | -47.89% |
| Dec 29, 2023 | 441.78K | -81.12% |
| Dec 30, 2022 | 2.34M | -79.95% |
| Dec 31, 2021 | 11.67M | -58.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Helix BioMedix | 393.24K |
| Actavia Life Sciences | 385.91K |
| Oncology Pharma | 376.48K |
| Ampio Pharmaceuticals | 295.36K |
| GB Sciences | 256.20K |
| Endonovo Therapeutics | 180.76K |
| Scorpius Holdings | 122.29K |
| Synairgen | 110.27K |